Reuters logo
BRIEF-Neurocrine Biosciences establishes wholesale acquisition cost for a 30-count bottle of Ingrezza 80mg capsules at $6,225
October 5, 2017 / 1:00 PM / 2 months ago

BRIEF-Neurocrine Biosciences establishes wholesale acquisition cost for a 30-count bottle of Ingrezza 80mg capsules at $6,225

Oct 5 (Reuters) - Neurocrine Biosciences Inc

* Neurocrine Biosciences Inc says has established wholesale acquisition cost for a 30-count bottle of Ingrezza 80 mg capsules at $6,225 - SEC filing Source text: (bit.ly/2y3e9oH) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below